CleanSpace Holdings has achieved a major regulatory milestone with European EN 12941 certification for its new AGILE loose-fitting PAPR, positioning the company for growth in its largest market and preparing for imminent Australian approval.
- European EN 12941 certification achieved for CleanSpace AGILE
- World’s first loose-fitting PAPR with patented AirSensit® technology
- Targets high-dust industrial sectors with 99.97% filtration efficiency
- Australian and New Zealand certification expected soon
- Nearly two years of R&D underpin product innovation
Breakthrough Certification Opens European Market
CleanSpace Holdings Limited (ASX:CSX) has cleared a significant regulatory hurdle with the successful EN 12941 (TH2) certification of its CleanSpace AGILE, a loose-fitting Powered Air Purifying Respirator (PAPR). This approval is a world first for a device combining loose fit with patented AirSensit® technology, delivering 99.97% filtration efficiency. The certification unlocks access to the UK and broader European industrial markets, CleanSpace’s largest revenue base to date.
The rigorous and lengthy approval process validates the AGILE’s technical credentials and positions CleanSpace as a scalable alternative to traditional respiratory protection brands amid tightening safety regulations. The product’s design caters specifically to workers in high-dust environments, including those with facial hair, addressing a niche often overlooked by conventional respirators.
Product Innovation Rooted in Extensive R&D
Nearly two years of focused research and development have culminated in the AGILE PAPR, reflecting CleanSpace’s commitment to innovation in respiratory protection. The device’s lightweight, belt- and hose-free design enhances user comfort and mobility, key factors driving worker adoption and compliance in demanding industrial settings.
Designed as a half facepiece, the AGILE fits all face types, including bearded users, without compromising on filtration performance or ease of use. These features aim to improve workplace safety outcomes and productivity, supporting employer respiratory programs with certified, user-friendly equipment.
Australian and New Zealand Approval on the Horizon
Following the European milestone, CleanSpace is progressing on certification for the Australian and New Zealand markets, with approval expected within months. This will materially expand the company’s addressable market in the Asia-Pacific region, complementing its established European footprint.
The timing of this approval is particularly relevant given CleanSpace’s recent challenges with certification delays, which had tempered revenue growth projections earlier this year. The imminent Australian certification offers a fresh catalyst to accelerate commercialisation and revenue momentum across key industrial sectors.
Large and Growing Market Opportunity
CleanSpace targets a broad industrial customer base spanning construction, mining, quarrying, manufacturing, and other environments with significant airborne particulate hazards. These sectors face increasing regulatory scrutiny and a growing emphasis on worker health and safety, creating a fertile market for advanced respiratory protection solutions like the AGILE.
The company’s patented AirSensit® technology and ergonomic design differentiate it from competitors, potentially enabling deeper penetration into both new and existing markets. This innovation aligns with CleanSpace’s strategic focus on leveraging R&D to meet evolving industrial safety standards and customer demands.
Bottom Line?
CleanSpace’s European certification for AGILE marks a pivotal step toward global commercialisation, with Australian approval poised to broaden its industrial reach and revenue potential.
Questions in the middle?
- How swiftly will CleanSpace convert certification milestones into meaningful sales growth in Europe and Australia?
- What competitive responses might emerge in the loose-fitting PAPR segment following this world-first product launch?
- How will ongoing regulatory changes in key markets shape demand for advanced respiratory protection solutions?